Dyne Therapeutics Inc (DYN)

23.05 -0.80 (-3.35%) USD  |  NASDAQ  |  Jan 08, 16:00
24.75 +1.70 (+7.38%) After-Hours: 20:00
More

Dyne Therapeutics Research and Development Expense (Annual): 210.76M for Dec. 31, 2023

Research and Development Expense (Annual) Chart

View Research and Development Expense (Annual) for DYN.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Research and Development Expense (Annual) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

R&D Expense Definition

View R&D Expense Definition
Start Trial

R&D expense is a line item from many companies' income statements.

Read full definition.

Research and Development Expense (Annual) Range, Past 5 Years

View Research and Development Expense (Annual) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Research and Development Expense (Annual) Benchmarks

View Research and Development Expense (Annual) Benchmarks
Start Trial
Vertex Pharmaceuticals Inc 3.69B
Avidity Biosciences Inc 190.97M
Catalyst Pharmaceuticals Inc 93.15M
Sarepta Therapeutics Inc 877.39M
Regenxbio Inc 232.27M